Vietnamese (HOSE) Pharma Industry Analysis
UpdatedJul 26, 2024
DataAggregated Company Financials
Companies19
- 7D-2.7%
- 3M12.7%
- 1Y11.6%
- YTD19.3%
Over the last 7 days, the Pharma industry has dropped 5.1%, driven by DHG Pharmaceutical declining 2.7%. In the past year, the industry has gained 9.1%. As for the next few years, earnings are expected to grow by 16% per annum.
Industry Valuation and Performance
Has the Vietnamese Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|
Loading
Current Industry PE
- Investors are optimistic on the Vietnamese Pharmaceuticals industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 20.6x which is higher than its 3-year average PE of 16.4x.
- The 3-year average PS ratio of 2.1x is lower than the industry's current PS ratio of 2.3x.
Past Earnings Growth
- Both revenue and earnings for companies in the Pharmaceuticals industry have remained mostly flat over the last three years.
- This means that sales and the cost of doing business have remained relatively consistent over this period and subsequently, so have profits.
Industry Trends
Which industries have driven the changes within the Vietnamese Healthcare industry?
| VN Market | -2.90% | |
| Healthcare | -3.11% | |
| Pharma | -2.74% | |
| Pharma | -2.74% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| PMC Pharmedic Pharmaceutical Medicinal | ₫96.80k | 4.1% +₫35.5b | 47.8% | PE14.6x | |
| PPP Phong Phu Pharmaceutical | ₫17.40k | 6.7% +₫9.7b | 13.0% | PE8.6x | |
| SPM SPM | ₫11.50k | 4.5% +₫6.9b | -16.7% | PE8.3x | |
| DVM Vietnam Medicinal Materials | ₫10.60k | 0.2% +₫713.0m | -13.5% | n/a |